Cargando...

Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is regarded as one of the most common dose-limiting adverse effects of several chemotherapeutic agents, such as platinum derivatives (oxaliplatin and cisplatin), taxanes, vinca alkaloids and bortezomib. CIPN affects more than 60% of patie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Rep
Autor principal: Sałat, Kinga
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329798/
https://ncbi.nlm.nih.gov/pubmed/32347537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-020-00106-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!